US Stock MarketDetailed Quotes

NRSN NeuroSense Therapeutics

Watchlist
  • 1.820
  • +0.090+5.20%
Close Mar 28 16:00 ET
24.87MMarket Cap-1921P/E (TTM)

NeuroSense Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-12.71%2.9M
-3.15%3.48M
11.55%3.64M
142.56%13.55M
105.41%3.38M
277.16%3.32M
277.50%3.59M
54.62%3.26M
93.46%5.59M
1.65M
Selling and administrative expenses
-21.14%1.27M
-8.72%1.57M
-21.60%1.54M
184.87%7.14M
14.76%1.84M
346.81%1.61M
279.69%1.72M
2,039.13%1.97M
537.40%2.51M
--1.6M
-General and administrative expense
-21.14%1.27M
-8.72%1.57M
-21.60%1.54M
184.87%7.14M
14.76%1.84M
346.81%1.61M
279.69%1.72M
2,039.13%1.97M
537.40%2.51M
--1.6M
Research and development costs
-4.75%1.63M
1.98%1.91M
61.88%2.1M
108.18%6.42M
3,256.52%1.54M
228.71%1.71M
275.50%1.87M
-35.81%1.3M
23.53%3.08M
--46K
Operating profit
12.71%-2.9M
3.15%-3.48M
-11.55%-3.64M
-142.56%-13.55M
-105.41%-3.38M
-277.16%-3.32M
-277.50%-3.59M
-54.62%-3.26M
-93.46%-5.59M
-1.65M
Net non-operating interest income expense
291.53%3.79M
-247.75%-1.86M
-145.17%-248K
105.98%69K
20.93%-914K
12,200.00%968K
-2,421.74%-534K
4,323.08%549K
-115,300.00%-1.15M
-1.16M
Non-operating interest income
----
----
-89.16%62K
--91K
-31,900.00%-960K
----
----
--572K
--0
---3K
Non-operating interest expense
3,570.00%2.2M
-1,926.67%-304K
1,247.83%310K
--15K
-5,200.00%-53K
--60K
-25.00%-15K
76.92%23K
--0
---1K
Total other finance cost
----
----
----
-99.39%7K
----
----
----
----
115,300.00%1.15M
----
Other net income (expense)
-57.67%1.14M
4,326.23%2.7M
Gain on sale of security
----
----
----
-57.67%1.14M
----
----
----
----
4,326.23%2.7M
----
Income before tax
126.19%784K
-50.10%-5.23M
-43.24%-3.89M
-205.37%-12.34M
-3,018.81%-3.15M
-237.16%-2.99M
-275.11%-3.48M
-27.82%-2.72M
-42.89%-4.04M
-101K
Income tax
Net income
126.19%784K
-50.10%-5.23M
-43.24%-3.89M
-205.37%-12.34M
-3,018.81%-3.15M
-237.16%-2.99M
-275.11%-3.48M
-27.82%-2.72M
-42.89%-4.04M
-101K
Net income continuous Operations
126.19%784K
-50.10%-5.23M
-43.24%-3.89M
-205.37%-12.34M
-3,018.81%-3.15M
-237.16%-2.99M
-275.11%-3.48M
-27.82%-2.72M
-42.89%-4.04M
---101K
Minority interest income
Net income attributable to the parent company
126.19%784K
-50.10%-5.23M
-43.24%-3.89M
-205.37%-12.34M
-3,018.81%-3.15M
-237.16%-2.99M
-275.11%-3.48M
-27.82%-2.72M
-42.89%-4.04M
-101K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
126.19%784K
-50.10%-5.23M
-43.24%-3.89M
-205.37%-12.34M
-3,018.81%-3.15M
-237.16%-2.99M
-275.11%-3.48M
-27.82%-2.72M
-42.89%-4.04M
-101K
Basic earnings per share
140.00%0.1
-41.94%-0.44
-37.50%-0.33
-64.62%-1.07
-2,825.56%-0.27
-203.17%-0.25
-265.57%-0.31
-23.66%-0.24
-151.53%-0.65
-0.0092
Diluted earnings per share
140.00%0.1
-41.94%-0.44
-37.50%-0.33
-64.62%-1.07
-2,825.56%-0.27
-203.17%-0.25
-265.57%-0.31
-23.66%-0.24
-151.53%-0.65
-0.0092
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -12.71%2.9M-3.15%3.48M11.55%3.64M142.56%13.55M105.41%3.38M277.16%3.32M277.50%3.59M54.62%3.26M93.46%5.59M1.65M
Selling and administrative expenses -21.14%1.27M-8.72%1.57M-21.60%1.54M184.87%7.14M14.76%1.84M346.81%1.61M279.69%1.72M2,039.13%1.97M537.40%2.51M--1.6M
-General and administrative expense -21.14%1.27M-8.72%1.57M-21.60%1.54M184.87%7.14M14.76%1.84M346.81%1.61M279.69%1.72M2,039.13%1.97M537.40%2.51M--1.6M
Research and development costs -4.75%1.63M1.98%1.91M61.88%2.1M108.18%6.42M3,256.52%1.54M228.71%1.71M275.50%1.87M-35.81%1.3M23.53%3.08M--46K
Operating profit 12.71%-2.9M3.15%-3.48M-11.55%-3.64M-142.56%-13.55M-105.41%-3.38M-277.16%-3.32M-277.50%-3.59M-54.62%-3.26M-93.46%-5.59M-1.65M
Net non-operating interest income expense 291.53%3.79M-247.75%-1.86M-145.17%-248K105.98%69K20.93%-914K12,200.00%968K-2,421.74%-534K4,323.08%549K-115,300.00%-1.15M-1.16M
Non-operating interest income ---------89.16%62K--91K-31,900.00%-960K----------572K--0---3K
Non-operating interest expense 3,570.00%2.2M-1,926.67%-304K1,247.83%310K--15K-5,200.00%-53K--60K-25.00%-15K76.92%23K--0---1K
Total other finance cost -------------99.39%7K----------------115,300.00%1.15M----
Other net income (expense) -57.67%1.14M4,326.23%2.7M
Gain on sale of security -------------57.67%1.14M----------------4,326.23%2.7M----
Income before tax 126.19%784K-50.10%-5.23M-43.24%-3.89M-205.37%-12.34M-3,018.81%-3.15M-237.16%-2.99M-275.11%-3.48M-27.82%-2.72M-42.89%-4.04M-101K
Income tax
Net income 126.19%784K-50.10%-5.23M-43.24%-3.89M-205.37%-12.34M-3,018.81%-3.15M-237.16%-2.99M-275.11%-3.48M-27.82%-2.72M-42.89%-4.04M-101K
Net income continuous Operations 126.19%784K-50.10%-5.23M-43.24%-3.89M-205.37%-12.34M-3,018.81%-3.15M-237.16%-2.99M-275.11%-3.48M-27.82%-2.72M-42.89%-4.04M---101K
Minority interest income
Net income attributable to the parent company 126.19%784K-50.10%-5.23M-43.24%-3.89M-205.37%-12.34M-3,018.81%-3.15M-237.16%-2.99M-275.11%-3.48M-27.82%-2.72M-42.89%-4.04M-101K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 126.19%784K-50.10%-5.23M-43.24%-3.89M-205.37%-12.34M-3,018.81%-3.15M-237.16%-2.99M-275.11%-3.48M-27.82%-2.72M-42.89%-4.04M-101K
Basic earnings per share 140.00%0.1-41.94%-0.44-37.50%-0.33-64.62%-1.07-2,825.56%-0.27-203.17%-0.25-265.57%-0.31-23.66%-0.24-151.53%-0.65-0.0092
Diluted earnings per share 140.00%0.1-41.94%-0.44-37.50%-0.33-64.62%-1.07-2,825.56%-0.27-203.17%-0.25-265.57%-0.31-23.66%-0.24-151.53%-0.65-0.0092
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg